Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Noah Doyle Insider Profile
4 Followers
Noah Doyle, Director at Qualigen Therapeutics, holds 739.33K shares in Qualigen Therapeutics (Ticker: QLGN). Most recently, Noah Doyle Sold $500,000 shares of Qualigen Therapeutics on Mar 16, 2020 for an estimated value of 110.00K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-14.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Noah Doyle holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 16, 2020 - Mar 16, 2021
Return:+36.00%
The most profitable trade made by Noah Doyle
Noah Doyle's Trading History
List of latest transactions for each holding click on a transaction to see Noah Doyle's performance on stock
You May Also Like
Noah Doyle insider profile FAQ
What is the percentage of profitable transactions made by Noah Doyle?
The percentage of profitable transactions made by Noah Doyle is 50%.
What is the average return per transaction made by Noah Doyle?
The average return per transaction made by Noah Doyle is -14.20%.
What stocks does Noah Doyle hold?
Noah Doyle holds: QLGN stocks.
What was Noah Doyle’s latest transaction?
Noah Doyle latest transaction was an Informative Sell of $110.00K.
What was Noah Doyle's most profitable transaction?
Noah Doyle’s most profitable transaction was an Informative Sell of QLGN stock on March 16, 2020. The return on the trade was 36.00%.
What is Noah Doyle's role in Qualigen Therapeutics?
Noah Doyle's role in Qualigen Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.